Approximately 25–30 % of adults and 3 % of children with acute lymphoblastic leukemia (ALL) express the oncogenic BCR-ABL protein, which results from a 9;22 chromosomal translocation known as the Philadelphia (Ph) chromosome [1]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.